{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:19:41Z","timestamp":1754151581587,"version":"3.41.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,19]]},"DOI":"10.7759\/cureus.88304","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T14:44:16Z","timestamp":1752936256000},"source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Heparin-Induced Thrombocytopenia (HIT) With Fondaparinux in a Patient With Liver Dysfunction"],"prefix":"10.7759","author":[{"given":"Spiros","family":"Delis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimosthenis","family":"Chrysikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Schizas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Charitaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Taprantzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Kylafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Shihada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Troupis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2007.059188","article-title":"Heparin induced thrombocytopenia: diagnosis and management update","volume":"83","author":"Ahmed I","year":"2007","unstructured":"Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: diagnosis and management update. Postgrad Med J. 2007, 83:575-82. 10.1136\/pgmj.2007.059188","journal-title":"Postgrad Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker A","year":"2012","unstructured":"Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2012, 120:4160-7. 10.1182\/blood-2012-07-443051","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001414","article-title":"A practical approach to evaluating postoperative thrombocytopenia","volume":"4","author":"Skeith L","year":"2020","unstructured":"Skeith L, Baumann Kreuziger L, Crowther MA, Warkentin TE. A practical approach to evaluating postoperative thrombocytopenia. Blood Adv. 2020, 4:776-83. 10.1182\/bloodadvances.2019001414","journal-title":"Blood Adv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2016.06.068","article-title":"Cross-reactivity between heparin and danaparoid antibodies in cardiac surgery","volume":"103","author":"Ronchard T","year":"2017","unstructured":"Ronchard T, Salaun E, Theron A, et al.. Cross-reactivity between heparin and danaparoid antibodies in cardiac surgery. Ann Thorac Surg. 2017, 103:e9-10. 10.1016\/j.athoracsur.2016.06.068","journal-title":"Ann Thorac Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-009-1464-x","article-title":"Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases","volume":"35","author":"Tardy-Poncet B","year":"2009","unstructured":"Tardy-Poncet B, Wolf M, Lasne D, Bauters A, Ffrench P, Elalamy I, Tardy B. Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases. Intensive Care Med. 2009, 35:1449-53. 10.1007\/s00134-009-1464-x","journal-title":"Intensive Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13219","article-title":"Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is 'shock liver' the unrecognized provocateur of ischemic limb necrosis?","volume":"14","author":"Warkentin TE","year":"2016","unstructured":"Warkentin TE, Pai M. Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is 'shock liver' the unrecognized provocateur of ischemic limb necrosis?. J Thromb Haemost. 2016, 14:231-5. 10.1111\/jth.13219","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-599498","article-title":"Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study","volume":"125","author":"Kang M","year":"2015","unstructured":"Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. Blood. 2015, 125:924-9. 10.1182\/blood-2014-09-599498","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker A","year":"2018","unstructured":"Cuker A, Arepally GM, Chong BH, et al.. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018, 2:3360-92. 10.1182\/bloodadvances.2018024489","journal-title":"Blood Adv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.408","article-title":"Think of HIT","author":"Warkentin TE","year":"2006","unstructured":"Warkentin TE. Think of HIT. Hematology Am Soc Hematol Educ Program. 2006, 408-14. 10.1182\/asheducation-2006.1.408","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-078014","article-title":"Heparin-induced thrombocytopenia: a historical perspective","volume":"112","author":"Kelton JG","year":"2008","unstructured":"Kelton JG, Warkentin TE. Heparin-induced thrombocytopenia: a historical perspective. Blood. 2008, 112:2607-16. 10.1182\/blood-2008-02-078014","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Warkentin TE","year":"2004","unstructured":"Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004, 126:311S-37S. 10.1378\/chest.126.3_suppl.311S","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.518563","article-title":"When heparins promote thrombosis: review of heparin-induced thrombocytopenia","volume":"111","author":"Jang IK","year":"2005","unstructured":"Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation. 2005, 111:2671-83. 10.1161\/CIRCULATIONAHA.104.518563","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-661215","article-title":"Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"127","author":"Nagler M","year":"2016","unstructured":"Nagler M, Bachmann LM, ten Cate H, ten Cate-Hoek A. Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2016, 127:546-57. 10.1182\/blood-2015-07-661215","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-09-0677","article-title":"Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis","volume":"106","author":"Cuker A","year":"2011","unstructured":"Cuker A. Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis. Thromb Haemost. 2011, 106:993-4. 10.1160\/TH11-09-0677","journal-title":"Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.08.006","article-title":"Thrombocytopenia in chronic liver disease: lessons from transplanted patients","volume":"47","author":"Laffi G","year":"2007","unstructured":"Laffi G, Tarquini R, Marra F. Thrombocytopenia in chronic liver disease: lessons from transplanted patients. J Hepatol. 2007, 47:625-9. 10.1016\/j.jhep.2007.08.006","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.21542\/gcsp.2018.15","article-title":"Heparin-induced thrombocytopenia (HIT): identification and treatment pathways","volume":"2018","author":"Fathi M","year":"2018","unstructured":"Fathi M. Heparin-induced thrombocytopenia (HIT): identification and treatment pathways. Glob Cardiol Sci Pract. 2018, 2018:15. 10.21542\/gcsp.2018.15","journal-title":"Glob Cardiol Sci Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta S","year":"2014","unstructured":"Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014, 58:515-23. 10.4103\/0019-5049.144643","journal-title":"Indian J Anaesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.11.019","article-title":"Disseminated intravascular coagulation and cirrhotic coagulopathy: overlap and differences. The current state of knowledge. Communication from the SSC of the ISTH","volume":"23","author":"Scarlatescu E","year":"2025","unstructured":"Scarlatescu E, Levy JH, Moore H, Thachil J, Iba T, Roberts LN, Lisman T. Disseminated intravascular coagulation and cirrhotic coagulopathy: overlap and differences. The current state of knowledge. Communication from the SSC of the ISTH. J Thromb Haemost. 2025, 23:1085-106. 10.1016\/j.jtha.2024.11.019","journal-title":"J Thromb Haemost"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199901000-00016","article-title":"Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis","volume":"229","author":"Gando S","year":"1999","unstructured":"Gando S, Nanzaki S, Kemmotsu O. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis. Ann Surg. 1999, 229:121-7. 10.1097\/00000658-199901000-00016","journal-title":"Ann Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5049.144666","article-title":"Disseminated intravascular coagulation","volume":"58","author":"Venugopal A","year":"2014","unstructured":"Venugopal A. Disseminated intravascular coagulation. Indian J Anaesth. 2014, 58:603-8. 10.4103\/0019-5049.144666","journal-title":"Indian J Anaesth"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12155","article-title":"Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines","volume":"11","author":"Wada H","year":"2013","unstructured":"Wada H, Thachil J, Di Nisio M, et al.. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013, 11:761-7. 10.1111\/jth.12155","journal-title":"J Thromb Haemost"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02313.x","article-title":"The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview","volume":"5","author":"Toh CH","year":"2007","unstructured":"Toh CH, Hoots WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007, 5:604-6. 10.1111\/j.1538-7836.2007.02313.x","journal-title":"J Thromb Haemost"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-162271","article-title":"Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients","volume":"113","author":"Tschudi M","year":"2009","unstructured":"Tschudi M, L\u00e4mmle B, Alberio L. Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients. Blood. 2009, 113:2402-9. 10.1182\/blood-2008-07-162271","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M136","article-title":"Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues","volume":"43","author":"Blackmer AB","year":"2009","unstructured":"Blackmer AB, Oertel MD, Valgus JM. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues. Ann Pharmacother. 2009, 43:1636-46. 10.1345\/aph.1M136","journal-title":"Ann Pharmacother"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2009.024","article-title":"Heparin-induced thrombocytopenia successfully treated with fondaparinux","volume":"64","author":"Seldrum S","year":"2009","unstructured":"Seldrum S, Lambert M, Hainaut P. Heparin-induced thrombocytopenia successfully treated with fondaparinux. Acta Clin Belg. 2009, 64:144-6. 10.1179\/acb.2009.024","journal-title":"Acta Clin Belg"},{"key":"ref26","article-title":"Heparin-induced thrombocytopenia in a patient treated with fondaparinux","volume":"8","author":"Ratuapli SK","year":"2010","unstructured":"Ratuapli SK, Bobba B, Zafar H. Heparin-induced thrombocytopenia in a patient treated with fondaparinux. Clin Adv Hematol Oncol. 2010, 8:61-5.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref27","article-title":"Heparin-induced thrombocytopenia associated with fondaparinux","volume":"8","author":"Chong BH","year":"2010","unstructured":"Chong BH, Chong JJ. Heparin-induced thrombocytopenia associated with fondaparinux. Clin Adv Hematol Oncol. 2010, 8:63-5.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035451","article-title":"Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism","volume":"349","author":"B\u00fcller HR","year":"2003","unstructured":"B\u00fcller HR, Davidson BL, Decousus H, et al.. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003, 349:1695-702. 10.1056\/NEJMoa035451","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Warkentin TE","year":"2008","unstructured":"Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008, 133:340S-80S. 10.1378\/chest.08-0677","journal-title":"Chest"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/13651820802074431","article-title":"Thrombotic complications following liver resection for colorectal metastases are preventable","volume":"10","author":"Morris-Stiff G","year":"2008","unstructured":"Morris-Stiff G, White A, Gomez D, Toogood G, Lodge JP, Prasad KR. Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford). 2008, 10:311-4. 10.1080\/13651820802074431","journal-title":"HPB (Oxford)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.01.069","article-title":"Heparin-induced thrombocytopenia after liver transplantation","volume":"40","author":"Kaneko J","year":"2008","unstructured":"Kaneko J, Sugawara Y, Tamura S, Togashi J, Matsui Y, Makuuchi M. Heparin-induced thrombocytopenia after liver transplantation. Transplant Proc. 2008, 40:1518-21. 10.1016\/j.transproceed.2008.01.069","journal-title":"Transplant Proc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2174\/1381612053382089","article-title":"Fondaparinux","volume":"11","author":"Tan KT","year":"2005","unstructured":"Tan KT, Lip GY. Fondaparinux. Curr Pharm Des. 2005, 11:415-9. 10.2174\/1381612053382089","journal-title":"Curr Pharm Des"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390387-treatment-of-heparin-induced-thrombocytopenia-hit-with-fondaparinux-in-a-patient-with-liver-dysfunction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T14:44:16Z","timestamp":1752936256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390387-treatment-of-heparin-induced-thrombocytopenia-hit-with-fondaparinux-in-a-patient-with-liver-dysfunction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.88304","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,19]]}}}